Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F J Giles

Showing results (1-10 of 130) with videos related to

Pageof 13
Sort By:
Stem Cells (Dayton, Ohio)|August 1, 1995
Current therapy of refractory multiple myelomaF J Giles
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 24, 1998
Monocyte-macrophages, granulocyte-macrophage colony-stimulating factor, and prolonged survival among patients with acute myeloid leukemia and stem cell transplantsF J Giles
Current Opinion in Hematology|July 1, 1994
Multiple myeloma and other differentiated B-cell disordersF J Giles
The Oncologist|November 9, 2001
The vascular endothelial growth factor (VEGF) signaling pathway: a therapeutic target in patients with hematologic malignanciesF J Giles
British Journal of Haematology|October 1, 1991
Maintenance therapy in the myeloproliferative disorders: the current optionsF J Giles
Leukemia|May 25, 2006
Clone wars in CMLF J Giles
Hematologic Pathology|January 1, 1995
Refractory multiple myeloma: recent advances in therapyF J Giles
Current Opinion in Biotechnology|December 1, 1991
alpha-Interferon in hematological malignanciesF J Giles, H Ozer
Haematologica|December 20, 1999
The potential of amifostine: from cytoprotectant to therapeutic agentV Santini, F J Giles
Leukemia & Lymphoma|April 1, 1996
Cutaneous manifestation of leishmaniasis 40 years after exposure in a patient with chronic lymphocytic leukaemiaA P Jewell, F J Giles
Pageof 13

Showing results (1-10 of 130) with videos related to

Sort By:
Pageof 13
Stem Cells (Dayton, Ohio)|August 1, 1995
Current therapy of refractory multiple myelomaF J Giles
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 24, 1998
Monocyte-macrophages, granulocyte-macrophage colony-stimulating factor, and prolonged survival among patients with acute myeloid leukemia and stem cell transplantsF J Giles
Current Opinion in Hematology|July 1, 1994
Multiple myeloma and other differentiated B-cell disordersF J Giles
The Oncologist|November 9, 2001
The vascular endothelial growth factor (VEGF) signaling pathway: a therapeutic target in patients with hematologic malignanciesF J Giles
British Journal of Haematology|October 1, 1991
Maintenance therapy in the myeloproliferative disorders: the current optionsF J Giles
Leukemia|May 25, 2006
Clone wars in CMLF J Giles
Hematologic Pathology|January 1, 1995
Refractory multiple myeloma: recent advances in therapyF J Giles
Current Opinion in Biotechnology|December 1, 1991
alpha-Interferon in hematological malignanciesF J Giles, H Ozer
Haematologica|December 20, 1999
The potential of amifostine: from cytoprotectant to therapeutic agentV Santini, F J Giles
Leukemia & Lymphoma|April 1, 1996
Cutaneous manifestation of leishmaniasis 40 years after exposure in a patient with chronic lymphocytic leukaemiaA P Jewell, F J Giles
Pageof 13